New hope for CF constipation: phase 3 trial tests approved IBS drug
NCT ID NCT06810167
Summary
This study is testing whether a medication called tenapanor, already approved for IBS with constipation, can help relieve constipation in people with cystic fibrosis. Twenty-five participants will take the drug twice daily for four weeks while tracking their bowel movements and symptoms. Researchers will measure changes in how often people have bowel movements and how much their constipation symptoms improve.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.